RECODE THERAPEUTICS

ReCode Therapeutics is a development-stage biopharmaceutical company focused on the correction of the nonsense mutations that account for 1/3 of all inherited diseases, including approximately 10% of cystic fibrosis. They have combined selected tRNAs with their unique and diverse proprietary delivery platforms to create and develop first-in-class suppressor tRNA-nanoparticle therapeutics for correcting nonsense mutations. ReCode’s diverse pipeline includes lead programs for primary ciliary dy... skinesia (PCD) and nonsense mutations in cystic fibrosis (CF). The company’s proprietary non-viral lipid nanoparticle platform enables the delivery of a variety of payloads, and precise organ targeting of nucleic acid and protein payloads via both systemic and local delivery. ReCode is leveraging its nanoparticle and nucleic acid technologies across multiple modalities, including mRNA-mediated protein replacement therapies, first-in-class tRNA NanoCorrectors for diseases caused by nonsense mutations, and gene editing. The company was founded in 2015 and is based in Dallas, Texas.

#SimilarOrganizations #People #Financial #Event #Website #More

RECODE THERAPEUTICS

Social Links:

Twitter

Industry:

Biopharma Biotechnology Health Care Pharmaceutical Wellness

Founded:

2015-01-01

Address:

Dallas, Texas, United States

Country:

United States

Website Url:

http://www.recodetx.com

Total Employee:

51+

Status:

Active

Contact:

469-306-1618

Email Addresses:

[email protected]

Total Funding:

282 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Universal Analytics Nginx Microsoft Exchange Online Office 365 Mail Nginx 1.14

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

eidos-therapeutics-logo

Eidos Therapeutics

Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

homology-medicines-logo

Homology Medicines

Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.

lyra-therapeutics-logo

Lyra Therapeutics

Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Current Advisors List

not_available_image

Rana Al-Hallaq Board Member @ ReCode Therapeutics
Board_member
2021-10-01

helen-s-kim_image

Helen S. Kim Board Member @ ReCode Therapeutics
Board_member

not_available_image

David Lockhart Board Member @ ReCode Therapeutics
Board_member
2020-01-01

michael-torres_image

Michael Torres Board Member @ ReCode Therapeutics
Board_member

shehnaaz-suliman_image

Shehnaaz Suliman Board of Directors @ ReCode Therapeutics
Board_member
2022-06-29

peter-thompson_image

Peter Thompson Board Member @ ReCode Therapeutics
Board_member

not_available_image

Rakhshita Dhar Board of Directors @ ReCode Therapeutics
Board_member
2022-06-29

ed-hurwitz_image

Ed Hurwitz Board Member @ ReCode Therapeutics
Board_member

Current Employees Featured

daniel-siegwart_image

Daniel Siegwart
Daniel Siegwart Co-Founder @ ReCode Therapeutics
Co-Founder
2015-01-01

michael-torres_image

Michael Torres
Michael Torres Co-Founder and Vice President of R&D @ ReCode Therapeutics
Co-Founder and Vice President of R&D

not_available_image

David Lockhart
David Lockhart President and CEO @ ReCode Therapeutics
President and CEO

philip-thomas_image

Philip Thomas
Philip Thomas Co-Founder @ ReCode Therapeutics
Co-Founder
2015-12-01

angele-maki_image

Angele Maki
Angele Maki Senior Vice President and Head of Business Development @ ReCode Therapeutics
Senior Vice President and Head of Business Development
2021-08-01

not_available_image

Nicholas P. France
Nicholas P. France Senior Vice President of Clinical Development @ ReCode Therapeutics
Senior Vice President of Clinical Development
2021-01-01

shehnaaz-suliman_image

Shehnaaz Suliman
Shehnaaz Suliman CEO & Board Member @ ReCode Therapeutics
CEO & Board Member
2022-01-01

Founder

daniel-siegwart_image

Daniel Siegwart

michael-torres_image

Michael Torres

philip-thomas_image

Philip Thomas

Investors List

matrix-capital-management_image

Key Employee Changes

Date	New article
2022-01-25	ReCode Enlists New CEO to Drive Assets into the Clinic
2022-01-10	ReCode Therapeutics names its CEO
2021-09-27	ReCode Therapeutics Appoints Nicholas P. France, M.D., as Senior Vice President of Clinical Development

Official Site Inspections

http://www.recodetx.com Semrush global rank: 3.74 M Semrush visits lastest month: 3.62 K

Host Informations
Whois Informations

Loading ...